These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26280708)

  • 1. Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis.
    Roginsky G; Alexoff A; Ehrenpreis ED
    J Clin Gastroenterol; 2015 Oct; 49(9):794-5. PubMed ID: 26280708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Naltrexone--high expectations to low dosages].
    Raknes G; Giverhaug T
    Tidsskr Nor Laegeforen; 2011 May; 131(8):844-6. PubMed ID: 21556092
    [No Abstract]   [Full Text] [Related]  

  • 3. Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
    Turel AP; Oh KH; Zagon IS; McLaughlin PJ
    J Clin Psychopharmacol; 2015 Oct; 35(5):609-11. PubMed ID: 26203498
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies to maximize the efficacy of naltrexone for alcohol dependence.
    O'Malley SS
    NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772
    [No Abstract]   [Full Text] [Related]  

  • 5. Naltrexone (vivitrol)--a once-monthly injection for alcoholism.
    Med Lett Drugs Ther; 2006 Jul; 48(1240):63-4. PubMed ID: 16874283
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to Degenhardt et al.: 'depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy'.
    Brewer C
    Drug Alcohol Rev; 2008 Jul; 27(4):447-8; author reply 448-9. PubMed ID: 18584398
    [No Abstract]   [Full Text] [Related]  

  • 7. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vivitrex (Alkermes/Cephalon).
    Heading CE
    Curr Opin Investig Drugs; 2006 Jan; 7(1):81-8. PubMed ID: 16425675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of pruritus with naltrexone, an orally active opiate antagonist.
    Metze D; Reimann S; Luger TA
    Ann N Y Acad Sci; 1999 Oct; 885():430-2. PubMed ID: 10816681
    [No Abstract]   [Full Text] [Related]  

  • 10. Naltrexone for the management of alcohol dependence.
    Anton RF
    N Engl J Med; 2008 Aug; 359(7):715-21. PubMed ID: 18703474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A morphine/naltrexone combination (Embeda) for pain.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):22-3. PubMed ID: 20336033
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
    Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy.
    Degenhardt L; Gibson A; Mattick RP; Hall W
    Drug Alcohol Rev; 2008 Jan; 27(1):1-3. PubMed ID: 18034375
    [No Abstract]   [Full Text] [Related]  

  • 14. Naltrexone in patients with bipolar disorder and alcohol dependence.
    Brown ES; Beard L; Dobbs L; Rush AJ
    Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
    Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
    JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone implants -- duration, tolerability and clinical usefulness. A pilot study.
    Waal H; Frogopsahl G; Olsen L; Christophersen AS; Mørland J
    Eur Addict Res; 2006; 12(3):138-44. PubMed ID: 16778434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
    Roth AS; Ostroff RB; Hoffman RE
    J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option?
    Ramanathan S; Panksepp J; Johnson B
    Psychosomatics; 2012; 53(6):591-4. PubMed ID: 22480625
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-Dose Naltrexone Treatment of Familial Benign Pemphigus (Hailey-Hailey Disease).
    Ibrahim O; Hogan SR; Vij A; Fernandez AP
    JAMA Dermatol; 2017 Oct; 153(10):1015-1017. PubMed ID: 28768314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose naltrexone and liver function safety.
    Marrazzi MA; Wroblewski JM; Kinzie J; Luby ED
    Am J Addict; 1997; 6(1):21-9. PubMed ID: 9097868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.